Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 25021-180

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 25021-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Azi08 0000 01)

Chemical structure of azithromycin monohydrate, the active ingredient in Azithromycin 500 mg/5 mL intravenous injection powder for solution by Sagent Pharmaceuticals.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Azi08 0000 02)

Label for Azithromycin for Injection USP, 500 mg per vial, equivalent to 500 mg azithromycin monohydrate, sterile single-dose vial for intravenous infusion only. Manufactured for Sagent Pharmaceuticals. Includes dosage information, storage instructions, and barcodes. The label is primarily white with blue and black text, and has Sagent logo in blue on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.